BSE filing, NSE: EMBDL. Summary written from the filing by ALFA Finder's alert engine.
Embassy Developments Ltd: key numbers
- Share price
- ₹51.24
- Market cap
- ₹7,182 Cr
- Revenue (annual)
- ₹1,732 Cr
- Net profit (annual)
- ₹-872.6 Cr
- P/E (TTM)
- -7.6×Sector 33.7×
- Promoter holding
- 42.68%+0.03% QoQ
- FII holding
- 24.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Embassy Developments Ltd
All →Embassy Developments Convertible Warrants
Embassy Developments' promoter group entity converted 2.32 crore warrants into equity at INR 111.51 each. The conversion is valued at INR 258.70 crore.
- Value
- ₹258.7 Cr
Embassy Developments Board Meeting Date
Embassy Developments intimated a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 05 Nov 2026.
Embassy Developments Convertible Warrants
Embassy Developments allotted 1,22,00,000 equity shares on conversion of preferential warrants. Paid-up capital rises by Rs 2.44 Crore to Rs 282.77 Crore.
- Value
- ₹2.44 Cr
Embassy Developments Convertible Warrants
Embassy Developments allotted 1,22,00,000 equity shares on conversion of promoter-group warrants, receiving Rs.102.03 Crore balance consideration. The conversion lifts promoter group holding to 43.62%.
- Value
- ₹102.0 Cr
Embassy Developments Convertible Warrants
Embassy Developments allotted 1.10 crore shares to a promoter entity on warrant conversion. Balance consideration of Rs.91.99 Crore received.
- Value
- ₹91.99 Cr
Embassy Developments Preferential Issue
Promoter entities disclosed acquisition of shares and warrants via preferential allotment, warrant conversion, and open market purchase, updating their total holdings in the company.
- Promoter stake change
- -0.65%
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.